COVID‐19 diagnosis and management: a comprehensive review
Severe acute respiratory syndrome coronavirus (SARS‐CoV)‐2, a novel coronavirus from
the same family as SARS‐CoV and Middle East respiratory syndrome coronavirus, has …
the same family as SARS‐CoV and Middle East respiratory syndrome coronavirus, has …
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
COVID-19 infection has a heterogenous disease course; it may be asymptomatic or causes
only mild symptoms in the majority of the cases, while immunologic complications such as …
only mild symptoms in the majority of the cases, while immunologic complications such as …
Coronavirus disease 2019 (COVID-19): current status and future perspectives
H Li, SM Liu, XH Yu, SL Tang, CK Tang - International journal of …, 2020 - Elsevier
ABSTRACT Coronavirus disease 2019 (COVID-19) originated in the city of Wuhan, Hubei
Province, Central China, and has spread quickly to 72 countries to date. COVID-19 is …
Province, Central China, and has spread quickly to 72 countries to date. COVID-19 is …
The epidemiology, diagnosis and treatment of COVID-19
P Zhai, Y Ding, X Wu, J Long, Y Zhong, Y Li - International journal of …, 2020 - Elsevier
In December 2019, the outbreak of the novel coronavirus disease (COVID-19) in China
spread worldwide, becoming an emergency of major international concern. SARS-CoV-2 …
spread worldwide, becoming an emergency of major international concern. SARS-CoV-2 …
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
ABSTRACT Recently, a novel coronavirus (2019-nCoV), officially known as severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China. Despite drastic …
respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China. Despite drastic …
[HTML][HTML] SARS-CoV-2: an emerging coronavirus that causes a global threat
J Zheng - International journal of biological sciences, 2020 - ncbi.nlm.nih.gov
An ongoing outbreak of pneumonia caused by a novel coronavirus, currently designated as
the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was reported recently …
the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was reported recently …
[HTML][HTML] Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19)
DG Ahn, HJ Shin, MH Kim, S Lee, HS Kim… - … of microbiology and …, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), which causes serious respiratory illness
such as pneumonia and lung failure, was first reported in Wuhan, the capital of Hubei …
such as pneumonia and lung failure, was first reported in Wuhan, the capital of Hubei …
COVID-19: Immunology and treatment options
S Felsenstein, JA Herbert, PS McNamara… - Clinical …, 2020 - Elsevier
The novel coronavirus SARS-CoV2 causes COVID-19, a pandemic threatening millions. As
protective immunity does not exist in humans and the virus is capable of esca** innate …
protective immunity does not exist in humans and the virus is capable of esca** innate …
COVID-19: A promising cure for the global panic
B Vellingiri, K Jayaramayya, M Iyer… - Science of the total …, 2020 - Elsevier
The novel Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, which is the
causative agent of a potentially fatal disease that is of great global public health concern …
causative agent of a potentially fatal disease that is of great global public health concern …
[HTML][HTML] Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective
Y Yang, MS Islam, J Wang, Y Li… - International journal of …, 2020 - ncbi.nlm.nih.gov
Abstract Currently, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2,
formerly known as 2019-nCoV, the causative pathogen of Coronavirus Disease 2019 …
formerly known as 2019-nCoV, the causative pathogen of Coronavirus Disease 2019 …